Letter: Mendelian randomization - new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply
- PMID: 37307554
- DOI: 10.1111/apt.17552
Letter: Mendelian randomization - new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply
Comment on
-
Systematic review-pancreatic involvement in inflammatory bowel disease.Aliment Pharmacol Ther. 2022 Jun;55(12):1478-1491. doi: 10.1111/apt.16949. Epub 2022 May 3. Aliment Pharmacol Ther. 2022. PMID: 35505465 Free PMC article.
-
Letter: Mendelian randomization-New perspective in inflammatory bowel disease and pancreatic cancer?Aliment Pharmacol Ther. 2023 Jul;58(1):143-144. doi: 10.1111/apt.17537. Aliment Pharmacol Ther. 2023. PMID: 37307560 No abstract available.
References
REFERENCES
-
- Min Y, Wei X, Peng X. Letter: mendelian randomization-new perspective in inflammatory bowel disease. Aliment Pharmacol Ther. 2023;58:143-4.
-
- Massironi S, Fanetti I, Viganò C, Pirola L, Fichera M, Cristoferi L, et al. Systematic review-pancreatic involvement in inflammatory bowel disease. Aliment Pharmacol Ther. 2022;55(12):1478-91.
-
- Lo B, Zhao M, Vind I, Burisch J. The risk of extraintestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2021;19(6):1117-38.e19.
-
- Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P, et al. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: a population-based cohort study. United Eur Gastroenterol J. 2022;10:212-24.
-
- de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49(2):256-61.
Publication types
MeSH terms
LinkOut - more resources
Medical